Effectiveness of a Pressure Ulcer Prevention Package (PUPP) for patients admitted in Intensive Care Units: An Experimental Study
Dr. Koushal Dave1, Ruchika Duggal Choudhary2
1College of Nursing, ABVIMS and Dr. R. M. L. Hospital. Delhi.
2Department of Psychiatry, ABVIMS and Dr. R. M. L. Hospital, New Delhi
*Corresponding Author E-mail: kaushal442@gmail.com, duggal.ruchika2008@gmail.com
ABSTRACT:
Introduction: Many critically ill patients admitted in ICUs are sedated, on mechanical ventilation and unable to change the position themselves. Therefore, these patients are at high risk of impaired skin integrity and leads to development of pressure ulcers. Objective: This study was done to assess the effectiveness of pressure ulcer prevention package in reducing the incidences of pressure ulcers among patients admitted in intensive care units (ICUs). Design: Experimental design (Pre test post test control group). Methods: Seventy patients from different ICUs of Dr. R. M. L. Hospital, Delhi were randomly allocated into two groups i.e. experimental and control groups. Experimental group received the intervention of pressure ulcer prevention package and the control group received routine skin care. Demographic and clinical data were collected by using demographic profile tool; standardised skin assessment tool and pressure ulcer staging tool. All the subjects were followed every third day from admission to discharge, death and up to a maximum 20 days. Data were analyzed using STATA 11.1 with the level of significance at p < 0.05. Descriptive and inferential statistics were used. Findings: The total seventy numbers of patients were recruited: 35 in experimental group and 35 in control group. Findings show that the sacrum and then heels were the most common areas of pressure ulcers among ICU patients. Pressure ulcer prevention package was significantly (p< 0.001) effective to delay the pressure ulcers related adverse events among patients of experimental group. Pressure ulcers related adverse events were developed earlier in control group i.e. 14% in experimental and 41% in control group. Number of pressure ulcers development were significantly (p<0.001) lower in experimental group (08/35) compared to control group (20/35). The experimental group had significantly less Stage I and Stage II pressure ulcers development compared to control group (p<0.001). Conclusions: Pressure ulcers prevention package was found to be significantly effective to reduce incidences, severity and total number of pressure ulcers among patients admitted in ICUs.
KEYWORDS: Pressure ulcers, pressure ulcer prevention package, ICU patients, skin integrity.
INTRODUCTION:
A pressure ulcer is localized injury to the skin and/or underlying tissue usually over a bony prominence, as a result of pressure, or pressure in combination with shear. A number of contributing or confounding factors are also associated with pressure ulcers; the significance of these factors is yet to be elucidated1,2,3. Pressure Ulcers (PUs) have been identified as a worldwide problem that contribute significantly to increasing healthcare costs, the compromising of an individual’s health, morbidity and in some cases mortality (Vollman, 2010)4. The prevalence worldwide of PUs in the ICU remains high and is documented between 3% and 50% (Berlowitz, 2014; Elliott, McKinley, and Fox, 2008)5. PUs are internationally recognized as an important and mostly avoidable indicator of health care quality6. Data shown that in the year January 2012 to December 2013 between 4 and 6% of patients in acute care settings and more than 5–10% of patients in non acute care had pressure ulcers. Pressure ulcers are accountable for 2% of preventable deaths7,8 PU severity is described using a Stage I through IV classification system, with Stage I representing the earliest stages of PU formation, and Stage IV representing the severest grade of PUs that are characterized by full thickness tissue loss and exposed bone, tendon or muscle tissue9. PUs occur most frequently over bony prominences and the most common PU vulnerable locations include the sacrum, coccyx, heels and ear.
Intensive care unit is an area designed to meet the special needs of the critically ill patients. Unlike the general ward, it is a closed unit for intensive care of the patients.10 Meeting the needs of the patient’s family members is an essential part of the responsibility of Intensive Care Unit physicians, nurses who are committed to easing the pain and suffering of these who have critically ill.11 Patients admitted to intensive care units (ICUs) are at a higher risk of developing PUs than patients admitted to general care. A review of ICU related literature from 2000 to 2005 indicated PU prevalence in the ICU of 49% and an incidence of 40.4%.12 The 2009 International Pressure Ulcer Prevalence Survey indicated that facility-acquired PU prevalence rates were highest (12.1%) in the medical ICU (MICU)13. Studies have reported an association between PUs and increased morbidity and mortality14. PUs can also lead to serious infectious complications, like bacteremia and sepsis15. The ICU mortality rate of infected patients was 25%, two times more than that for non-infected patients in an international study.16 The prevalence of infection and mortality rates are higher in countries with limited resources associated with the quality of care.17 Nurses have good knowledge regarding pressure ulcers but they have poor practices regarding pressure ulcers prevention.18 Because of these factors, PUs have been reported to extend the duration of a hospital stay by a median of 4.31 days. Due to the adverse effects associated with PUs, PU prevention in the ICU is critically important.
Robb et al. (2010)19 suggest that the care bundle approach is more effective than clinical guidelines. This may be because of the mandatory and audited nature of care bundles, whilst clinical guidelines are regarded as advisory. The term care bundle refers to the implementation of a set of three to six mandatory interventions that are targeted toward a specific procedure, symptom, or treatment (Horner and Bellamy, 2012)20. A care bundle approach has been frequently used in clinical practice as it provides improvement in the delivery of evidence-based care and results in patient outcomes.20
Care bundles are thought of as systems that are greater than the sum of their parts; only when the interventions are performed simultaneously can the care bundle achieve its maximum effect. Implementation of individual elements of the care bundle violates the spirit of the cluster intervention strategy and will not produce the desired results. Different cluster bundles have been specifically designed for the management of different diseases, and some common cluster bundle elements can be incorporated or eliminated to meet the specific challenges posed by individual diseases.
While a number of studies reveal a positive link between the care bundle and patient outcomes in the ICU (Baldelli and Paciella, 2008)21, PU prevention guidelines/bundles for intensive care patients are not well defined. The intensive care context poses special challenges to preventing PU development due to the high acuity of patients and the highly invasive nature of interventions and therapies that critically ill patients receive.
The existing PU care bundle was based on the best available evidence and guidelines: the International guidelines and the guidelines of the Registered Nurses Association of Ontario (RNAO).25 The current review further develops and specializes the recommendations of the PU prevention care bundle for adult patients hospitalized in ICUs. This review identifies five key elements of PU prevention and care use of devices, securement of lines, education and training, positioning, nutritional therapy, skin care, skin assessment, risk assessment
These strategies can be grouped together in a bundle to reduce the incidence of PU development for critically ill patients in the ICU.
Given the high PU incidence and the evidence that suggests the benefits of a PU prevention bundle, use of a PU prevention bundle is likely to improve patient outcomes and reduce the morbidity and mortality rates of ICU patients. Hence, researcher developed the PUPP to identify its effects on pressure ulcers among ICU patients. Objective: This study will evaluate the effectiveness of a PU prevention bundle for patients admitted in ICUs. Aim: The aim of this study was to test the effectiveness of a PU prevention bundle in reducing incidence of PUs in critically ill patients.
METHODS:
Experimental pre test post test control group design was used. All critically ill patients with different disease conditions admitted in intensive care units of Dr. R. M.L. Hospital, New Delhi were enrolled. Ethical clearance for the study was obtained from institute Ethics Committee.
Sample and Sampling technique:
Total 70 subjects who met the eligibility criteria were randomly allocated to two groups: control group (35) and experiment group (35). Subjects in experimental group received Pressure Ulcer Prevention Package (PUPP) and subjects in control group received standard care.
Data were collected during April 2019 to November 2019. ICUs are specialist areas that deliver complex multisystem support for adults needing comprehensive intensive care and monitoring by specialist care staff. Patients admitted in ICUs have similar high acuity and medical diagnoses, including cardiovascular illness, respiratory diseases, cancer, renal dysfunction, burns, sepsis, and multi-trauma injuries such as head injury. Each ICU was staffed with approximately 30 nursing officers (NOs). All NOs who provide care for ICU patients have qualifications of bachelor of nursing degree with many also having a diploma in nursing. ICU staffing ratio is one NO to two or three mechanically ventilated patients and three Senior Nursing Officers (SNOs) charge nurse per shift for each of the three 8-hr shifts per day.
All the subjects who were admitted during the study collection period were included in the study if they were 18 years of age or older and were expected to stay in the ICU for more than 24 hr. Those excluded were patients admitted to the ICU with an existing PU, those with a medical condition that contraindicated the bundle intervention and those diagnosed with any stage PU in the first 24 hr of admission to the ICU.
Measures:
Demographic and clinical data:
Demographic data like age, sex, nationality and clinical data like diagnosis on admission, comorbidities, length of time in operating theatre prior to ICU admission, mechanical ventilation (yes or no), ICU length of stay in days and ICU outcome were collected from participants admitted in ICUs.
Skin assessment tool:
A tool to record a standardized approach to skin examination and assessment was designed by the researchers using a standard physical assessment technique and common areas for PU development.
PU staging:
PUs were defined and staged according to EPUAP and NPUAP. PUs was identified as skin or mucosal ulcers. PU site was identified on the data collection form by drawing a circle over the relevant area in the body figure.
Intervention: Pressure Ulcer Prevention Package (PUPP):
The PU prevention package was designed to reduce PU incidence or severity, to be suitable for NOs to deliver and to fit within the care delivery structure of the ICUs. Table 1 shows the comparison of PUPP which was provided to subjects of experimental group and standard care to control group.
Table 1: Comparison of PUPP versus Standard Care
|
Intervention |
PUPP |
Standard Care |
|
Risk Assessment |
Completion and documentation of Braden risk assessment scale within 24 hr of ICU admission and daily thereafter. |
No PU risk assessment scale was used. |
|
Skin Assessment |
Physical assessment of the patient’s skin was undertaken and documented within 4 hr of admission and every 8 hr thereafter. |
Physical assessement was done as per routine ICU policy. |
|
Skin care |
Bathed once per day was given to the patients by using cleansing agent . Skin was treated with a topical moisturizer. |
Bath once per day as per ICU care |
|
Nutritional Therapy |
Nutrional assessment and support was maintained by the nursing officers with the assistance of dietician |
Nutrional support was maintained as standard care. |
|
Positioning |
Patients was repositioned strictly 2 hourly and when required (SOS). Patients heels was elevated and supported. Drawsheets was used to transfer and lift patients. Where clinically possibly patients was mobilized daily to sit out of bed on chair.Position was documented, including the time of repositioning and position adopted. |
As per routine care. No documentation was done |
|
Use of Devices |
Pneumatic air mattress was used for all the patients |
Air mattress might not be used for all the patients. |
|
Securement of Lines |
All the invasive and non invasive lines was secured properly |
Securment was done adequately. |
|
Education and Training |
Education and Training was provided to Nursing officers who were caring patients |
No addditional training was given to Nursing Officers. |
Process of Care:
Nursing officers process of care performance based on the PU prevention package and standard skin care (Table 1) were measured using a checklist for compliance (yes or no).
Endpoints:
The primary endpoint of the study was ICU patient stay up to a maximum of 20 days. A 20-day endpoint was chosen based on the findings of a previous study showing mean time to develop a PU was 10.09 days in this patient population (median 9 days, SD 4.6195 days, range 5– 23 days; Tayyib et al., 2015)22. Secondary endpoints were death or discharge from the ICU prior to 20 days.
Procedure for data collection:
Data was collected from April 2019 to November 2019. All critically ill patients admitted in ICUs of Dr. R. M. L. Hospital and met the inclusion criteria were enrolled in study. Random assignment to either of the two groups: experimental and control groups was done based on randomization table. Demographic related data was collected. The researcher attended each ICU every second day to screen, recruit, and collect data using the data collection tools. All patients were followed until discharge, death, or up to a maximum of 20 ICU days, whichever occurred first. For intervention group, the ICU NOs were informed about the study’s PU prevention package and one-to-one bedside education provided by the researcher. The training and education program consisted of PowerPoint presentation with handout, consultation and clarification with the researcher, which continued throughout the study. NOs’ compliance to the intervention was supervised by senior nursing officers and feedback was provided. The control group received usual standard skin care and PU prevention practices were followed as per policies of the ICU.
RESULTS:
Demographic and clinical characteristics of patients:
As shown in Table 2, the mean age of the subjects was 47 in experimental group and 52 in control group. Majority of the subjects were male in both the groups. Prior to admission in ICUs of the patients, mean length of the time in operation theaters was 39±23.12 in experimental group and 22±13.65 in control group. Mean length of the time in emergency department was almost similar for both the groups 44±29.37 and 47.9± 43.25 respectively. Most of the subjects in both the groups had comorbid condition like hypertension and diabetes. Majority of the subjects, 57% and 60% of both the groups admitted in ICUs with medical related illnesses. Mean length of stay in ICU was almost similar in both the groups, 11.16±8.9 days and 10.6±7.58 days respectively. Approximately 58% of the subjects were discharged, 14% and 11% stayed for 20 days and 25% and 31% subjects of both the groups were expired before endpoint. Similar 70% of the subjects of both the groups were on mechanical ventilation. Mean frequency of repositioning was 2±2.13 hours in experimental group and 4.16±1.33 hours in control group. There were no significant differences between either group in all demographic characteristics and all clinical characteristics, with the exception of time in the operation room (Table 2)
Table 2: Demographic and clinical characteristics of patients
|
Variables |
Experimental Group (n = 35) |
Control Group (n = 35) |
P value |
|
Age (Mean ± SD) |
47 ± 21 |
52 ± 19 |
0.169 |
|
Sex (number, %) Male Female |
25 (71.4%) 10 (28.6%) |
24(68.6%) 11(31.42%) |
0.712 |
|
Length of the time in OT in minutes (Mean ± SD) |
39 ± 23.12 |
22 ± 13.65 |
0.018 |
|
Length of the time in ED in minutes (Mean ± SD) |
44 ± 29.37 |
47.9±43.25 |
0.95 |
|
Comorbidities (Number, %) Hypertension IDDM PVD Other Nil |
14(40%) 11(31.4) 2.5 (7.1) 12(17.1) 12(16) |
19(54.2) 15(42.85) 7.5(21.42) 18(51.42) 9(13) |
0.314 |
|
Diagnosis (Number, %) Trauma Medical related illness Post surgery Sepsis |
9 (25.71) 20 (57.14) 3 (8.6) 3 (8.6) |
5(14.28) 21(60) 5(14.28) 4(11.42) |
0.256 |
|
ICU length of stay in days (Mean ± SD) |
11.16 ± 8.9 |
10.6 ± 7.58 |
0.912 |
|
Outcome(Number, %) Discharged Upto 20 days Death |
21(58.57) 5 (14.28) 9 (25.71) |
20(57.14) 4(11.42) 11(31.42) |
0.407 |
|
Mechanical Ventilation (yes) |
70% |
72% |
0.788 |
|
Frequency of repositioning in hours (Mean ± SD) |
2 ± 2.13 |
3.16 ± 1.33 |
0.11 |
PU Prevention Bundle versus Standard Care:
As shown in table 3, 22% (8/35) subjects had PUs incidences after implementation of PUPP in experimental group and 65% (23/35) subjects had PUs incidences with standard care in control group. Maximum one ulcer was found in 4 subjects of experimental group and in control group, one ulcer was found in 13 subjects and two ulcers were assessed in 6 subjects. 6 subjects had PU stage 1, 3 subjects had PU stage 2 and 1 subject had deep injury in experimental group. In control group, 15 subjects had PU stage 1, 12 had PU stage 2, 4 subjects had PU stage 3 and 4 and 4 subjects had deep injury. Majority of the subjects in both the groups, 5 in experimental group and 13 in control group had PUs at sacral area.
Results show that PUPP was significantly (p<0.004) effective to reduce PUs incidences among subjects admitted in ICUs. Study results also found that number of PUs per patient were significantly (p<0.005) low after implementation of PUPP. Skin stages of PUs was found significantly low (p<0.004) with PUPP than standard PU care among ICU subjects.
Table 3: Clinical Characteristics of Patients with pressure ulcers
(N = 70)
|
Variables |
Experimental Group (n = 35) |
Control Group (n = 35) |
P value |
|
Total number of PUs incidences n (%) |
8 (22.85) |
23 (65.71) |
0.004 |
|
Numbers of PUs per patient One (n) Two (n) Three (n) Four (n) |
4 3 1 0 |
13 6 3 1 |
0.005 |
|
Stages of skin PUs (n) Deep Injury PU Stage I PU Stage II PU stage III and IV |
1 6 3 0 |
4 15 12 4 |
0.002 |
|
Skin Ulcer Location (n) Elbow Shoulder Ear Sacrum Buttock Heel Knee |
0 1 0 5 2 0 0 |
1 2 1 13 4 1 1 |
0.004 |
DISCUSSION:
The results of this study support the effectiveness of the PU prevention package in adult ICU patients showing significant reduction in the incidence of hospital-acquired PUs (HAPUs) and total number of PUs per patient in the intervention group. The PU prevention package, based on the most recent available evidence of PU prevention strategies, combined several measures that targeted risk factors. Therefore, we could not estimate the effect of individual prevention measures (Horner and Bellamy, 2012)23. The package approach may be considered successful because a marked reduction in PU incidence recorded.
The incidence rate of PUs now is similar to that reported in other international studies (Gunningberg et al., 2012; Stotts et al., 2013)24. Our analyses revealed that the implementation of the PU prevention package has significantly reduced the severity of PUs. Further, the prevention package has been shown to be effective in other international studies, which reported that regular assessment of the patient’s skin and mucous membranes around and underneath devices, with regular repositioning of devices, is essential to reduce PUs incidence (Coyer et al., in press)25. These findings confirmed that the PU prevention package results in improvement in patient outcomes in tertiary care setting.
The study by Weststrate and Heule26, found that there are no significant differences between the types of reducing pressure. Mattresses like low air loss and alternating pressure air mattresses in ICU patients. Additionally, there is limited evidence for low air loss mattresses in reducing the incidence of pressure ulcers in ICU patients. Moreover, one study suggested that low-air-loss beds are more effective than standard foam beds in preventing pressure ulcers for persons in ICU27. The package approach is more efficient than a single intervention in changing practice (Horner and Bellamy, 2012)28. However, lack of compliance by Nursing Officers (NO) can hinder the success of package. Soban, Hempel, Munjas, Miles, and Rubenstein (2011)29 suggested that successful reporting of the intervention (PU prevention package) should include the intervention’s effect on patient’s outcome (PU incidence) and process of care, to understand the extent of conducting each intervention. This study showed increased compliance of most processes of care with implementation of the PU prevention package; patients were repositioned more frequently, had an improvement in ongoing care, and the patients’ heels were elevated and supported with greater frequency.
Interestingly, this study found that control group delivery of the PU prevention processes of care were dependent on Nursing Officers’ clinical decision and provided no uniformity of care. Several studies argue that standardization, high reliability and compliance of package implementation will improve PU prevention in the ICU (Chaboyer et al., 2013; Revello and Fields, 2012)30.
Evidence suggests it is no longer sufficient to rely on Nursing Officers’ clinical judgment in this area— the risk of variance in practice and key elements being omitted is too high. This study showed a high Nursing Officers’ compliance to delivery of the PU prevention package, thus enabling the PU prevention package to be successfully translated in the clinical practice (ICU). Further, this study suggests that using a package approach, with extensive education and training, regular feedback of the performance and increased Nursing Officers awareness about the extent of the problem will improve NO’s compliance and the reduction of PUs in the ICU.
LIMITATIONS AND FUTURE RECOMMENDATIONS:
This study was conducted in single setting with small sample size therefore generalizability of the findings are limited. Assessment of PU prevention package in a different organizational setting may be required for additional resources and training. Measuring prevalence and incidence of PUs regularly, increasing staff education and awareness about the problem, using PU prevention strategies and implementing evidence-based practice toward PU prevention will positively impact the quality of care and patient outcomes.
IMPLICATIONS:
This package had significantly positive effects on reducing PUs especially incidence and severity of PUs. Utilizing a package approach through skin assessment and utilization of the knowledge to practice is essential for PU-related outcomes. Early identifying risk factors for PU development and high–risk patients and linking with relevant nursing interventions will achieve the desired outcome of PU reduction in the ICU, consequently improving quality of care and patient safety.
CONCLUSION:
The results of this study showed significant improvements in reducing PUs and PU-related events through the implementation of the PU prevention package in ICUs. It would appear that the use of the PU package can reduce PU incidence, severity and total number of PUs per patient. This comprehensive package was evidence based on PU prevention strategies for skin or mucosal PUs, it should also be recognized that it is highly effective by increased staff awareness about PU prevention, staff training and education may also contribute to successful results in improving patient care.
REFERENCES:
1. Nurhusien Nuru, et al. Knowledge and practice of nurses towards prevention of pressure ulcer and associated factors in Gondar University Hospital, Northwest Ethiopia. BMC Nursing 2015, 14:34; 2-8.
2. Abebe Dilie and Daniel Mengistu. Assessment of Nurses’ Knowledge, Attitude and Perceived Barriers to Expressed Pressure Ulcer Prevention Practice in Addis Ababa Government Hospitals, Addis Ababa, Ethiopia. Advances in Nursing 2015 (1);1-11.
3. Uba et al. Knowledge, attitude and practice nurses towards prevention of pressure ulcers in university of Maiduguri teaching hospital, Borno state, Nort eastern Nigeri. International Journal of nursing and midwifery. 2015, 7(4); 54-60.
4. Vollman, K. M. (2010). Introduction to progressive mobility. Critical Care Nurse, 30(2; Suppl.), S3–S5.
5. Berlowitz, D. (2014). Incidence and prevalence of pressure ulcers. In G. A. Compton and D. R. Thomas (Eds.), Pressure ulcers in the aging population: A guide for clinicians (Vol. 1, pp. 19–26). Totowa, NJ: Humana Press.
6. National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and treatment of pressure ulcers: clinical practice guideline. In: Haesler Emily, editor. Osborne Park, Western Australia: Cambridge Media; 2014.
7. D. M. Durkin and R. May, Stop the Pressure, February 2015, http://nhs.stopthepressure.co.uk/whats-happening.html.
8. J. C. Maravilla, M. H. Lucero, T. E. Y. Alejo et al “The knowledge of nurses in pressure ulcer prevention and their attitude towards the use of Braden scale,” in Proceedings of the Sigma Theta Tau International’s 23rd. International Nursing Research Congress. July 2012.
9. National Pressure Ulcer Advisory Panel. Pressure ulcers: avoidable or unavoidable? Results of the National Pressure
10. Takori MSM. Intensive care unit. The internet Journal of Health 2004; 3
11. Azolay E, Schlemmer B. A multicenter study on Meeting the needs of intensive care unit patient’s family. Am J Respiratory Critical Care Med 2001 Jan;163(1):135-9.
12. Shahin ES, Dassen T, Halfens RJ. Pressure ulcer prevalence and incidence in intensive care patients: a literature review. Nurs Crit Care 2008;13(2):71e9.
13. VanGilder C, Amlung S, Harrison P, Meyer S. Results of the 2008e2009 International Pressure Ulcer Prevalence Survey and a 3-year, acute care, unit-specific analysis. Ostomy Wound Manage 2009;55(11):39e45.
14. Graves N, Birrell F, Whitby M. Effect of pressure ulcers on length of hospital stay. Infect Control Hosp Epidemiol 2005;26(3):293e7.
15. Krupp AE, Monfre J. Pressure ulcers in the ICU patient: an update on prevention and treatment. Curr Infect Dis Rep 2015;17(3):468.
16. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009 Dec; 302(21):2323-9.
17. Dunser MW, Bataar O, Tsenddorj G, Lundeg G, Torgersen C, Romand JA. Differences in critical care practice between an industrialized and a developing country. Wien Klin Wochenschr 2008 Sep;120(19-20):600-7.
18. J. Beckford-Ball, Strikethrough Resistant Technology Can Meet the Demands of Healthcare, Pressure Ulcer Prevention, 2013. Vol. 4
19. Robb, E., Jarman, B., Suntharalingam, G., Higgens, C., Tennant, R., and Elcock, K. (2010). Quality improvement report using care bundles to reduce in-hospital mortality: Quantitative survey. British Medical Journal, 340(7751), 861–863.
20. Horner, D. L., and Bellamy, M. C. (2012). Care bundles in intensive care. Continuing Education in Anaesthesia, Critical Care and Pain, 12(4), 199–202.
21. Baldelli, P., and Paciella, M. (2008). Creation and implementation of a pressure ulcer prevention bundle improves patient outcomes. American Journal of Medical Quality, 23(2), 136–142.Ulcer Advisory Panel Consensus Conference. Ostomy Wound Manage 2011;57(2):24e37.
22. Tayyib, N., Coyer, F., and Lewis, P. (2015). Saudi Arabian adult intensive care unit pressure ulcer incidence and risk factors: A prospective cohort study. Advance online publication. International Wound Journal. doi:10.1111/iwj.12406.
23. Horner, D. L., and Bellamy, M. C. (2012). Care bundles in intensive care. Continuing Education in Anaesthesia, Critical Care and Pain, 12(4), 199–202.
24. Gunningberg, L., Donaldson, N., Aydin, C., and Idvall, E. (2012). Exploring variation in pressure ulcer prevalence in Sweden and the USA: Benchmarking in action. Journal of Evaluation in Clinical Practice, 18(4), 904–910.
25. Coyer, F., Stotts, N., and Blackman, V. (2014). A prospective window into medical device-related pressure ulcers in intensive care. International Wound Journal, 11(6), 656–664.
26. Weststrate, J. T. M. and Heule, F. (2001) Prevalence of PU, risk factors and use of pressure ulcer-relieving mattresses in ICU patients. Connect the World of Critical Care Nursing, 1 (3), 77–82.
27. Inman, K. J., Sibbald, W. J., Rutledge, F. S. and Clark, B. J. (1993) Clinical utility and cost- effectiveness of an air suspension bed in the prevention of pressure ulcers. The Journal of the American Medical Association (JAMA), 269 (9), 1139–1143.
28. Horner, D. L., and Bellamy, M. C. (2012). Care bundles in intensive care. Continuing Education in Anaesthesia, Critical Care and Pain, 12(4), 199–202.
29. Soban, L. M., Hempel, S., Munjas, B. A., Miles, J., andRubenstein, L. V. (2011). Preventing pressure ulcers in hospitals: A systematic review of nurse-focused quality improvement interventions. Joint Commission Journal on Quality and Patient Safety, 37(6), 245.
30. Chaboyer, W., Chamberlain, D., Hewson-Conroy, K., Grealy, B., Elderkin, T., Brittin, M., Thalib, L. (2013). Safety culture in Australian intensive care units: Establishing a baseline for quality improvement. American Journal of Critical Care, 22(2), 93–102.
Received on 06.05.2020 Modified on 13.06.2020
Accepted on 15.07.2020 ©A&V Publications All right reserved
Int. J. of Advances in Nur. Management. 2020; 8(4):273-278.
DOI: 10.5958/2454-2652.2020.00061.X